Zeh HJ - Search Results

1

Assessment of quality outcomes for robotic pancreaticoduodenectomy: identification of the learning curve.

Boone BA, Zenati M, Hogg ME, Steve J, Moser AJ, Bartlett DL, Zeh HJ, Zureikat AH. Boone BA, et al. Among authors: zeh hj. JAMA Surg. 2015 May;150(5):416-22. doi: 10.1001/jamasurg.2015.17. JAMA Surg. 2015. PMID: 25761143

2

Gadolinium-enhanced 3D MRA prior to isolated hepatic perfusion for metastases.

Zeh H, Choyke PL, Alexander HR, Bartlett DL, Libutti SK, Chang R, Summers RM. Zeh H, et al. J Comput Assist Tomogr. 1999 Sep-Oct;23(5):664-9. doi: 10.1097/00004728-199909000-00003. J Comput Assist Tomogr. 1999. PMID: 10524842

3

Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers.

Zeh HJ, Bartlett DL. Zeh HJ, et al. Cancer Gene Ther. 2002 Dec;9(12):1001-12. doi: 10.1038/sj.cgt.7700549. Cancer Gene Ther. 2002. PMID: 12522439 Review.

4

Pancreaticoduodenectomy in the presence of superior mesenteric venous obstruction.

Koniaris LG, Staveley-O'Carroll KF, Zeh HJ, Perez E, Jin XL, Maley WR, Zabari G, Bartlett DL, Khanna A, Franceschi D, Schoeniger LO. Koniaris LG, et al. Among authors: zeh hj. J Gastrointest Surg. 2005 Sep-Oct;9(7):915-21. doi: 10.1016/j.gassur.2005.04.005. J Gastrointest Surg. 2005. PMID: 16137584

5

Natural killer-dendritic cell cross-talk in cancer immunotherapy.

Kalinski P, Mailliard RB, Giermasz A, Zeh HJ, Basse P, Bartlett DL, Kirkwood JM, Lotze MT, Herberman RB. Kalinski P, et al. Among authors: zeh hj. Expert Opin Biol Ther. 2005 Oct;5(10):1303-15. doi: 10.1517/14712598.5.10.1303. Expert Opin Biol Ther. 2005. PMID: 16197336 Review.

6

The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2.

Guo ZS, Naik A, O'Malley ME, Popovic P, Demarco R, Hu Y, Yin X, Yang S, Zeh HJ, Moss B, Lotze MT, Bartlett DL. Guo ZS, et al. Among authors: zeh hj. Cancer Res. 2005 Nov 1;65(21):9991-8. doi: 10.1158/0008-5472.CAN-05-1630. Cancer Res. 2005. PMID: 16267024

7

Analysis of loss of heterozygosity for tumor-suppressor genes can accurately classify and predict the clinical behavior of mucinous tumors arising from the appendix.

Maheshwari V, Tsung A, Lin Y, Zeh HJ 3rd, Finkelstein SD, Bartlett DL. Maheshwari V, et al. Among authors: zeh hj 3rd. Ann Surg Oncol. 2006 Dec;13(12):1610-6. doi: 10.1245/s10434-006-9081-1. Epub 2006 Sep 29. Ann Surg Oncol. 2006. PMID: 17009159

8

High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists.

Popovic PJ, DeMarco R, Lotze MT, Winikoff SE, Bartlett DL, Krieg AM, Guo ZS, Brown CK, Tracey KJ, Zeh HJ 3rd. Popovic PJ, et al. Among authors: zeh hj 3rd. J Immunol. 2006 Dec 15;177(12):8701-7. doi: 10.4049/jimmunol.177.12.8701. J Immunol. 2006. PMID: 17142771

9

Multianalyte profiling of serum cytokines for detection of pancreatic cancer.

Zeh HJ, Winikoff S, Landsittel DP, Gorelik E, Marrangoni AM, Velikokhatnaya L, Winans MT, Lee K, Moser A, Bartlett D, Lotze MT, Siegfried JM, Whitcomb D, Papacristou G, Slivka A, Bigbee WL, Lokshin AE. Zeh HJ, et al. Cancer Biomark. 2005;1(6):259-69. doi: 10.3233/cbm-2005-1601. Cancer Biomark. 2005. PMID: 17192050

10

A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.

Yang S, Guo ZS, O'Malley ME, Yin X, Zeh HJ, Bartlett DL. Yang S, et al. Among authors: zeh hj. Gene Ther. 2007 Apr;14(8):638-47. doi: 10.1038/sj.gt.3302914. Epub 2007 Feb 1. Gene Ther. 2007. PMID: 17268533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters